Regenerative injections may be considered for patients with chronic plantar fasciosis who have not improved sufficiently despite an accurate diagnosis and a well-conducted programme of conservative treatment. They are not usually the first treatment for new heel pain, and they should not be used as a substitute for appropriate rehabilitation, footwear advice, load management, strengthening or other evidence-based treatments.
The term regenerative injection generally refers to treatments intended to stimulate or support the body’s healing response. The two most commonly discussed options for plantar fasciosis are dextrose prolotherapy and platelet-rich plasma, usually called PRP. These treatments are different in their preparation and proposed mechanisms, but both aim to influence tissue repair and remodelling rather than simply suppress pain temporarily.
Research suggests that dextrose prolotherapy may reduce pain and improve function in some patients with chronic plantar fasciopathy. However, studies use different dextrose concentrations, injection techniques and treatment schedules, and the most effective protocol has not yet been established. Systematic reviews have therefore described prolotherapy as a potentially useful treatment while emphasising the need for larger, higher-quality studies with standardised protocols.
PRP is prepared from a sample of the patient’s own blood and contains a concentrated level of platelets and biological signalling proteins involved in tissue repair. Reviews suggest that PRP may provide better medium-term pain improvement than corticosteroid injections in some patients. However, PRP preparation methods vary significantly between clinics and research studies, making it difficult to identify one consistently effective formulation or treatment protocol.
Regenerative injections are generally considered only after the plantar fascia has been confirmed as the primary pain generator. Diagnostic ultrasound may demonstrate plantar fascia thickening, reduced tissue organisation or areas of degeneration. It can also help identify partial tears and assess nearby structures. Ultrasound guidance allows the needle and affected tissue to be visualised during the procedure and helps ensure that treatment is directed accurately to the intended area.
Not every patient with persistent heel pain requires an injection into the plantar fascia. Poor response to previous treatment may occur because the diagnosis is incomplete or because another condition is contributing to the symptoms. Baxter’s nerve entrapment, calcaneal bone marrow oedema, stress injury, heel fat-pad pathology and referred pain can all produce symptoms that resemble plantar fasciosis. Injecting the plantar fascia is unlikely to resolve pain arising primarily from a nerve, bone or another structure.
Regenerative injections should also not be viewed as a stand-alone treatment. Even when an injection is appropriate, rehabilitation remains necessary to progressively restore the plantar fascia’s ability to tolerate load. Recovery may include temporary activity modification, supportive footwear, progressive strengthening and a gradual return to walking, running or sport. The injection may assist the healing process, but it cannot correct ongoing overload on its own.
Patients should understand that improvement is usually gradual rather than immediate. Symptoms may temporarily increase after the procedure, and meaningful improvement may develop over several weeks or months. Results vary, and neither prolotherapy nor PRP can guarantee complete tissue regeneration or permanent pain relief.
Regenerative injections may be reasonable for carefully selected patients, but the research does not show that they are automatically superior to shockwave therapy or structured rehabilitation. A meta-analysis comparing PRP with shockwave therapy found a statistically greater reduction in pain with PRP, but the difference did not reach the threshold considered clinically important. This reinforces the need to select treatment according to the individual diagnosis rather than assuming that an injection is necessarily the more advanced or effective option.
The most important decision is therefore not simply which injection to use. It is whether the plantar fascia is genuinely responsible for the pain, whether appropriate conservative treatment has been completed and whether an injection is likely to add meaningful benefit to a comprehensive recovery programme.